Ovarian cancer: Involvement of the matrix metalloproteinases

Linah Al-Alem, Thomas E. Curry

Research output: Contribution to journalReview articlepeer-review

77 Scopus citations


Ovarian cancer is the leading cause of death from gynecologic malignancies. One of the reasons for the high mortality rate associated with ovarian cancer is its late diagnosis, which often occurs after the cancer has metastasized throughout the peritoneal cavity. Cancer metastasis is facilitated by the remodeling of the extracellular tumor matrix by a family of proteolytic enzymes known as the matrix metalloproteinases (MMPs). There are 23 members of the MMP family, many of which have been reported to be associated with ovarian cancer. In the current paradigm, ovarian tumor cells and the surrounding stromal cells stimulate the synthesis and/or activation of various MMPs to aid in tumor growth, invasion, and eventual metastasis. The present review sheds light on the different MMPs in the various types of ovarian cancer and on their impact on the progression of this gynecologic malignancy.

Original languageEnglish
Pages (from-to)R55-R64
Issue number2
StatePublished - Aug 1 2015

Bibliographical note

Publisher Copyright:
© 2015 Society for Reproduction and Fertility.

ASJC Scopus subject areas

  • Reproductive Medicine
  • Embryology
  • Endocrinology
  • Obstetrics and Gynecology
  • Cell Biology


Dive into the research topics of 'Ovarian cancer: Involvement of the matrix metalloproteinases'. Together they form a unique fingerprint.

Cite this